Works matching IS 00070920 AND DT 2020 AND VI 123


Results: 248
    1
    2
    4
    5
    6
    7
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    EGFR as a stable marker of prostate cancer dissemination to bones.

    Published in:
    2020
    By:
    • Nastały, Paulina;
    • Stoupiec, Sara;
    • Popęda, Marta;
    • Smentoch, Julia;
    • Schlomm, Thorsten;
    • Morrissey, Colm;
    • Żaczek, Anna Joanna;
    • Beyer, Burkhard;
    • Tennstedt, Pierre;
    • Graefen, Markus;
    • Eltze, Elke;
    • Maiuri, Paolo;
    • Semjonow, Axel;
    • Pantel, Klaus;
    • Brandt, Burkhard;
    • Bednarz-Knoll, Natalia
    Publication type:
    journal article
    25
    26
    27
    28

    Overcoming the blood-brain barrier by Annexin A1-binding peptide to target brain tumours.

    Published in:
    2020
    By:
    • Nonaka, Motohiro;
    • Suzuki-Anekoji, Misa;
    • Nakayama, Jun;
    • Mabashi-Asazuma, Hideaki;
    • Jarvis, Donald L.;
    • Yeh, Jiunn-Chern;
    • Yamasaki, Kazuhiko;
    • Akama, Tomoya O.;
    • Huang, Chun-Teng;
    • Campos, Alexandre Rosa;
    • Nagaoka, Masato;
    • Sasai, Toshio;
    • Kimura-Takagi, Itsuko;
    • Suwa, Yoichi;
    • Yaegashi, Takashi;
    • Shibata, Toshiaki K.;
    • Sugihara, Kazuhiro;
    • Nishizawa-Harada, Chizuko;
    • Fukuda, Minoru;
    • Fukuda, Michiko N.
    Publication type:
    journal article
    29

    Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1.

    Published in:
    2020
    By:
    • Kalaw, Emarene;
    • Lim, Malcolm;
    • Kutasovic, Jamie R.;
    • Sokolova, Anna;
    • Taege, Lucinda;
    • Johnstone, Kate;
    • Bennett, James;
    • Saunus, Jodi M.;
    • Niland, Colleen;
    • Ferguson, Kaltin;
    • Gresshoff, Irma;
    • Bettington, Mark;
    • Pathmanathan, Nirmala;
    • Tse, Gary M.;
    • Papadimos, David;
    • Pathmanathan, Rajadurai;
    • Harris, Gavin;
    • Yamaguchi, Rin;
    • Tan, Puay Hoon;
    • Fox, Stephen
    Publication type:
    journal article
    30
    31
    32
    33
    34

    Breast cancer survival in Nordic BRCA2 mutation carriers-unconventional association with oestrogen receptor status.

    Published in:
    2020
    By:
    • Olafsdottir, Elinborg J.;
    • Borg, Ake;
    • Jensen, Maj-Britt;
    • Gerdes, Anne-Marie;
    • Johansson, Anna L. V.;
    • Barkardottir, Rosa B.;
    • Johannsson, Oskar T.;
    • Ejlertsen, Bent;
    • Sønderstrup, Ida Marie Heeholm;
    • Hovig, Eivind;
    • Lænkholm, Anne-Vibeke;
    • Hansen, Thomas van Overeem;
    • Olafsdottir, Gudridur H.;
    • Rossing, Maria;
    • Jonasson, Jon G.;
    • Sigurdsson, Stefan;
    • Loman, Niklas;
    • Nilsson, Martin P.;
    • Narod, Steven A.;
    • Tryggvadottir, Laufey
    Publication type:
    journal article
    35
    36
    37
    38

    Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy.

    Published in:
    2020
    By:
    • Stelwagen, Johannes;
    • Lubberts, Sjoukje;
    • Steggink, Lars C.;
    • Steursma, Gerrie;
    • Kruyt, Lara M.;
    • Donkerbroek, Jan Willem;
    • van Roon, Arie M.;
    • van Gessel, Anne I.;
    • van de Zande, Saskia C.;
    • Meijer, Coby;
    • Gräfin zu Eulenburg, Christine H.;
    • Oosting, Sjoukje F.;
    • Nuver, Janine;
    • Walenkamp, Annemiek M. E.;
    • Jan de Jong, Igle;
    • Lefrandt, Joop D.;
    • Gietema, Jourik A.
    Publication type:
    journal article
    39

    Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer.

    Published in:
    2020
    By:
    • Voss, Martin H.;
    • Gordon, Michael S.;
    • Mita, Monica;
    • Rini, Brian;
    • Makker, Vicky;
    • Macarulla, Teresa;
    • Smith, David C.;
    • Cervantes, Andrés;
    • Puzanov, Igor;
    • Pili, Roberto;
    • Wang, Ding;
    • Jalal, Shadia;
    • Pant, Shubham;
    • Patel, Manish R.;
    • Neuwirth, Rachel l.;
    • Enke, Aaron;
    • Shou, Yaping;
    • Sedarati, Farhad;
    • Faller, Douglas V.;
    • Burris III, Howard A.
    Publication type:
    journal article
    40
    41
    42
    43

    Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancer.

    Published in:
    2020
    By:
    • Greene, Michelle K.;
    • Chen, Ting;
    • Robinson, Eifion;
    • Straubinger, Ninfa L.;
    • Minx, Charlene;
    • Chan, Darren K. W.;
    • Wang, Jun;
    • Burrows, James F.;
    • Van Schaeybroeck, Sandra;
    • Baker, James R.;
    • Caddick, Stephen;
    • Longley, Daniel B.;
    • Mager, Donald E.;
    • Straubinger, Robert M.;
    • Chudasama, Vijay;
    • Scott, Christopher J.
    Publication type:
    journal article
    44
    45
    46
    47

    Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08.

    Published in:
    2020
    By:
    • Masuishi, Toshiki;
    • Tsuji, Akihito;
    • Kotaka, Masahito;
    • Nakamura, Masato;
    • Kochi, Mitsugu;
    • Takagane, Akinori;
    • Shimada, Ken;
    • Denda, Tadamichi;
    • Segawa, Yoshihiko;
    • Tanioka, Hiroaki;
    • Hara, Hiroki;
    • Sagawa, Tamotsu;
    • Watanabe, Takanori;
    • Takahashi, Takao;
    • Negoro, Yuji;
    • Manaka, Dai;
    • Fujita, Hideto;
    • Suto, Takeshi;
    • Takeuchi, Masahiro;
    • Ichikawa, Wataru
    Publication type:
    journal article
    48
    49
    50